These are KEI’s post hearing responses to three questions regarding USTR’s Special 301 list. KEI-Special301-28Feb2024 One question was a follow up to KEI’s testimony that USTR should develop a policy on the trade related aspects of biomedical R&D that does… Continue Reading →
KEI filed these comments today with USTR on its 2024 Special 301 list. KEI-Special301comments-30jan2024
The 154th session of the World Health Organization’s (WHO) Executive Board will take place from 22 January 2024 to 27 January 2024 in Geneva, Switzerland. Rule 8 of the Rules of Procedure of the Executive Board of the World Health… Continue Reading →
Today KEI hosted a side event at WIPO on the United States use of FAR 52.227-1. These are the slides I used.Slide 11 provides a link to more than 350 contracts that have his clause for a variety of purposes.… Continue Reading →
The USITC has issued a 497 page report on the WTO negotiations over TRIPS and COVID. https://www.usitc.gov/publications/332/pub5469.pdf The USITC release states: The U.S. International Trade Commission (USITC) today released a report about COVID-19 diagnostics and therapeutics and certain flexibilities under… Continue Reading →
KEI-NTIA-AI-Accountability-RFC KEI response to NTIA request for comments on AI Accountability Policy, expressing concerns over trade agreement provisions which limit the transparency of source code and algorithms RE: Notice by the National Telecommunications and Information Administration on 04/13/2023, Document Citation:… Continue Reading →
ITC-KEI-COVID-TRIPS-30March2023
USTR-Special301-2023-KEI-coments KEI comments on the 2023 USTR Special 301 Review Comments provided by James Love, on behalf of Knowledge Ecology International 110 Maryland Avenue, NE, Washington, DC 20002 Telephone: +1.202.332.2670 James.Love@KEIOnline.Org In response to Federal Register Notice: Docket Number USTR-2022-0016… Continue Reading →
This was sent today. Final.Ambassador.Tai.26oct2022
Selected differences between Article 30, 31 and 44 of the WTO TRIPS Agreement as regards non-voluntary use of patented inventions KEI Briefing Note 2022:3 October 12, 2022 KEI-BN-2022-3-TRIPS-Differences-3articles